Form 8-K - Current report:
SEC Accession No. 0001293971-24-000090
Filing Date
2024-12-13
Accepted
2024-12-13 16:04:48
Documents
14
Period of Report
2024-12-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20241212.htm   iXBRL 8-K 32722
2 EX-3.1 exhibit3120241212.htm EX-3.1 13138
  Complete submission text file 0001293971-24-000090.txt   179521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20241212.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20241212_lab.xml EX-101.LAB 22783
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20241212_pre.xml EX-101.PRE 13051
16 EXTRACTED XBRL INSTANCE DOCUMENT blue-20241212_htm.xml XML 3094
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 241548320
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)